Valuation: Fresenius SE & Co. KGaA

Capitalization 23.66B 27.28B 22.29B 20.25B 37.47B 2,363B 42.21B 264B 101B 1,082B 102B 100B 3,979B P/E ratio 2025 *
15.2x
P/E ratio 2026 * 12.7x
Enterprise value 34.99B 40.33B 32.95B 29.94B 55.4B 3,493B 62.42B 390B 149B 1,600B 151B 148B 5,883B EV / Sales 2025 *
1.54x
EV / Sales 2026 * 1.44x
Free-Float
73.04%
Yield 2025 *
2.5%
Yield 2026 * 2.72%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.91%
1 week-4.52%
Current month-2.71%
1 month-4.59%
3 months+6.19%
6 months+26.54%
Current year+25.25%
More quotes
1 week 41.41
Extreme 41.41
44.38
1 month 41.41
Extreme 41.41
44.4
Current year 31.6
Extreme 31.6
44.4
1 year 27.81
Extreme 27.81
44.4
3 years 19.69
Extreme 19.69
44.4
5 years 19.69
Extreme 19.69
47.6
10 years 19.69
Extreme 19.69
80.07
More quotes
Manager TitleAgeSince
Chief Executive Officer 56 30/09/2022
Director of Finance/CFO 45 31/08/2022
Compliance Officer 48 -
Director TitleAgeSince
Director/Board Member 70 19/05/2015
Director/Board Member 64 12/05/2016
Director/Board Member 51 31/12/2007
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.91%-4.52%+48.18%+43.77% 26.89B
+0.17%+1.70%+11.56%+118.08% 90.66B
-0.40%-1.32%+9.13%-24.92% 84.55B
+2.83%-1.83%-14.31%+25.28% 23.02B
+0.19%+0.29%+26.28%+15.76% 21.88B
-0.19%-0.43%+29.83%+37.35% 20.07B
+0.26%+2.21%+24.24%+217.30% 15.57B
+0.85%-6.80%+27.37%-6.67% 15.51B
-1.33%-0.85%+35.20%+17.37% 14.18B
+4.45%-1.59%+29.78%+235.14% 13B
Average +0.77%-1.44%+22.73%+67.85% 32.53B
Weighted average by Cap. +0.39%-0.75%+17.36%+55.44%
See all sector performances

Financials

2025 *2026 *
Net sales 22.7B 26.17B 21.39B 19.43B 35.95B 2,267B 40.51B 253B 96.92B 1,039B 98.22B 96.12B 3,818B 23.83B 27.47B 22.44B 20.39B 37.73B 2,379B 42.51B 266B 102B 1,090B 103B 101B 4,006B
Net income 1.53B 1.77B 1.44B 1.31B 2.43B 153B 2.73B 17.09B 6.54B 70.07B 6.63B 6.49B 258B 1.87B 2.15B 1.76B 1.6B 2.95B 186B 3.33B 20.8B 7.96B 85.31B 8.07B 7.9B 314B
Net Debt 11.32B 13.05B 10.67B 9.69B 17.93B 1,131B 20.2B 126B 48.34B 518B 48.99B 47.94B 1,904B 10.59B 12.21B 9.98B 9.07B 16.77B 1,058B 18.9B 118B 45.21B 484B 45.82B 44.84B 1,781B
More financial data * Estimated data
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (39.1%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. ; - other (1.7%).
Employees
175,202
More about the company
Date Price Change Volume
20/06/25 42.01 +0.91% 2,050,598
19/06/25 41.63 -0.98% 683,742
18/06/25 42.04 -2.26% 1,254,594
17/06/25 43.01 -2.21% 867,694
16/06/25 43.98 -0.05% 588,406

Delayed Quote Xetra, June 20, 2025 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
42.01EUR
Average target price
48.86EUR
Spread / Average Target
+16.32%
Consensus

Quarterly revenue - Rate of surprise